NORTH CAROLINA -- A warning to consumers about fake Ozempic (semaglutide). The FDA issued this alert saying counterfeits have been found in the US drug supply chain. The FDA and the manufacturer of ...
With obesity now affecting 41.9% of adults in the United States, according to the Centers for Disease Control and Prevention (CDC), medications like semaglutide have gained enormous attention.
PLAINSBORO, N.J., April 14, 2025 /PRNewswire/ -- Novo Nordisk has become aware of several hundred units of Ozempic ® (semaglutide) injection 1 mg distributed outside the Novo Nordisk authorized supply ...
Using GLP-1s or considering it? New global research reveals social and psychological consequences for everyday lives.
PLAINSBORO, N.J., March 29, 2025 /PRNewswire/ -- Novo Nordisk today presented results from STRIDE, its phase 3b trial investigating the effects of once-weekly Ozempic ® (semaglutide) injection 1 mg in ...
Zepbound and Ozempic are both prescription drugs part of the GLP-1 agonist drug class. While their uses are different, they do have some similarities, such as dosing schedule and form. This article ...
Zepbound (tirzepatide) and Ozempic (semaglutide) are brand-name subcutaneous injections. They’re both prescribed for weight loss and weight management, but only Zepbound has been FDA-approved for this ...
Vulnerable individuals are using weight-loss medication in dangerous and unhealthy ways, experts have revealed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback